Genomics

Dataset Information

0

BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting C-Myc and S100A16 in Glioblastoma [ChIP-seq]


ABSTRACT: Glioblastoma (GBM) in children is a relatively more common primary central nervous system tumor with a high degree of malignancy, high mortality, and complex surgical complete resection.. GNE987 is a newly developed von Hippel-Lindau tumor suppressor (VHL)-based pan-BET-targeting PROTAC, which can bind to the target proteins (BET proteins, including BRD2, BRD3, and BRD4) and recruit them to the ubiquitin/ proteasome system for degradation. However, the function of GNE987 has not been assessed in GBM cells so far. In the present study, ChIP-Seq analysis was performed to explore the effect of GNE987 on GBM cells.

ORGANISM(S): Homo sapiens

PROVIDER: GSE202484 | GEO | 2022/11/09

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-08-08 | GSE243673 | GEO
2022-03-23 | GSE190002 | GEO
2022-03-23 | GSE194430 | GEO
2023-10-16 | GSE244893 | GEO
2022-11-09 | GSE202362 | GEO
2022-08-29 | GSE193767 | GEO
2024-05-22 | PXD030774 | Pride
2024-10-08 | PXD049407 | Pride
2015-02-23 | E-GEOD-62736 | biostudies-arrayexpress
2022-12-09 | GSE208184 | GEO